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Background: Avian influenza remains a serious threat to human health. The consequence of human infection
varies markedly among different subtypes of avian influenza viruses. In addition to viral factors, the difference in
host cellular response is likely to play a critical role. This study aims at elucidating how avian influenza infection
perturbs the host’s miRNA regulatory pathways that may lead to adverse pathological events, such as cytokine
storm, using the miRNA microarray approach.
Results: The results showed that dysregulation of miRNA expression was mainly observed in highly pathogenic
avian influenza A H5N1 infection. We found that miR-21*, miR-100*, miR-141, miR-574-3p, miR-1274a and miR1274b
were differentially expressed in response to influenza A virus infection. Interestingly, we demonstrated that miR-141,
which was more highly induced by H5N1 than by H1N1 (p < 0.05), had an ability to suppress the expression of a
cytokine - transforming growth factor (TGF)-β2. This was supported by the observation that the inhibitory effect
could be reversed by antagomiR-141.
Conclusions: Since TGF-β2 is an important cytokine that can act as both an immunosuppressive agent and a
potent proinflammatory molecule through its ability to attract and regulate inflammatory molecules, and previous
report showed that only seasonal influenza H1N1 (but not the other avian influenza subtypes) could induce a
persistent expression of TGF-β2, we speculate that the modulation of TGF-β2 expression by different influenza
subtypes via miR-141 might be a critical step for determining the outcome of either normal or excessive
inflammation progression.
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Avian influenza remains a serious threat to poultry and
human health. From December 2003 to April 2013,
more than 600 human infections and 374 deaths have
been reported to the World Health Organization [1].
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reproduction in any medium, provided the orAsia to many parts of the world. To date, there is still
no sign that the epidemic is under control.
While it has been well documented that infection with
H5N1 results in high mortality in humans [2-5], the cellular
pathway leading to such adverse outcome is unknown. The
naive host immune system cannot be the sole explanation
as infection of other avian influenza viruses, e.g. H9N2,
only results in mild infections [6]. While the predilection of
H5N1 towards cells in the lower respiratory tract contrib-
utes to the development of severe pneumonia [7], the avail-
able clinico-pathological evidence indicates that the
infected patients progress to multi-organ failure early in the
course of illness, and the degree of organ failure is out of
proportion to the involvement of infection [8-10]. Cytokine. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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features that distinguish H5N1 infection from severe sea-
sonal influenza. These indirect mechanisms seem to play
an even more important role than direct cell killing due to
lytic viral infection.
MiRNAs, a new class of endogenous, 18–23 nucleotide
long noncoding and single-stranded RNAs, were re-
cently discovered in both animals and plants. They trig-
ger translational repression and/or mRNA degradation
mostly through complementary binding to the 3′UTR of
target mRNAs. Studies have shown that miRNAs can
regulate a wide array of biological processes such as cell
proliferation, differentiation, and apoptosis [11-14].
Given the nature of viruses, being intracellular parasites
and using the cellular machinery for their survival and
replication, the success of the virus essentially depends on
its ability to effectively and efficiently use the host machin-
ery to propagate itself. This dependence on the host also
makes it susceptible to the host gene-regulatory mecha-
nisms, i.e. the host miRNAs may also have direct or indir-
ect regulatory role on viral mRNAs expression.
Recently, several reports indicated that miRNAs can
target influenza viruses and regulate influenza virus rep-
lication. In one report, 36 pig-encoded miRNAs and 22
human-encoded miRNAs were found to have putative
targets in swine influenza virus and Swine-Origin 2009
A/H1N1 influenza virus genes, respectively [15]. In an-
other report, results showed that miR-323, miR-491 and
miR-654 could inhibit replication of H1N1 influenza A
virus through binding to the conserved region of the
PB1 gene [16]. These miRNAs could downregulate PB1
expression through mRNA degradation instead of trans-
lation repression [16]. Besides targeting influenza virus,
cellular miRNAs were also implicated in the lethal infec-
tions of mice with a highly pathogenic 1918 pandemic
H1N1 influenza virus [17]. A previous study on miRNA
gene expression in avian influenza virus infected chicken
showed that miR-146, which was previously reported to
be associated with immune-related signal pathways in
mammals, was found to be differentially expressed in
infected tissues [18]. Moreover, a study of profiling cellu-
lar miRNAs of lung tissue from cynomolgus macaques
infected with a highly pathogenic H5N1 avian and a less
pathogenic 1918 H1N1 reassortant virus identified that
23 miRNAs were associated with the extreme virulence
of highly pathogenic H5N1 avian virus [19]. Also, the
predicted gene targets of the identified miRNAs were
found to be associated with aberrant and uncontrolled
inflammatory responses and increased cell death [19].
This study aimed at elucidating how avian influenza
infection perturbs the human gene regulatory pathways
leading to adverse pathological events, e.g. cytokine
storm. We hypothesized that miRNAs could be involved
in influenza virus infection response and beganaddressing this hypothesis using a microarray-based
screening. The ultimate goal of this study is to generate
essential information for further studies to identify novel
intervention targets to ameliorate the adverse outcome
of infection.
Results
Differential miRNA expression in H5N1 and H1N1
influenza virus infected cells
The cell line - NCI-H292, infected with various prepara-
tions of influenza viruses was analysed for miRNA ex-
pression profiles subsequently. A list of differentially
expressed miRNA was identified for subtypes H1N1 and
H5N1, respectively (Table 1), and the temporal pattern
of expression was delineated. Among the listed profiles
of differentially up-regulated miRNA, it was found that
miR-141, miR-181c*, miR-210, miR29b, miR-324-5p, and
miR-663 were up-regulated (>1.5-fold, p<0.05) at 3-hour
post-infection with subtype H5 as compared with non-
infected control cells. At this time point, only miR-141 was
found to be slightly induced in subtype H1 infected cells.
At 6-hour post-infection, it was found that miR-483-3p
was up-regulated (>3-fold, p<0.05) in H5N1 infected cells
while miR-663 was found to be up-regulated (>1.5-fold,
p<0.05) in H1N1 infected cells. At 18 and 24-hour post-
infection, miR-923, miR-1246, miR-574-3p, and miR-663
were up-regulated (>3-fold, p<0.05) in H5N1 infected cells.
For H1N1 infected cells, at 18 and 24-hour post-infection,
miR-188-5p, miR-1260, miR-1274a, miR-1274b, miR141,
miR183*, miR-18b, miR-19a, miR21*, miR-301a, miR-572,
miR-720, and miR-939 were found to be up-regulated
(>1.5-fold, p<0.05) (Table 1).
Among the listed profiles of differentially down-
regulated miRNA as compared with non-infected control
cells, it was found that miR-574-5p was down regulated
(>2-fold, p<0.05) in H5N1 infected cells at 3-hour post-
infection. For H1N1 infected cells, miR-23a, miR-574-3p
and miR-574-5p were down-regulated (>=2-fold, p<0.05)
at this time point. At 6-hour post-infection, miR-126,
miR-20a*, miR-362-5p, miR-378, miR-454, and miR574-
5p were found to be down-regulated (>2-fold, p<0.05) in
H5N1 infected cells. At the same time point (6-hour),
miR-15a*, miR-1825, miR-183*, miR-34b, miR-494, and
miR-574-5p were found to be down-regulated (>1.5-fold,
p<0.05) in H1N1 infected cells. Furthermore, at 18, and
24-hour post-infection, miR-1260, miR-1274a, miR-1274b,
miR-141, miR-18b, miR-21*, miR-720, miR-100*, miR-
1260, miR1280, and miR21* were found to be down-
regulated (>3-fold, p<0.05) in H5N1 infected cells. At
these time points, only miR-1274, and miR-17* were
found to be down-regulated (>1.8-fold, p<0.05) in H1N1
infected cells (Table 1).
From the results, we found that similar changes in
miRNA profiles were observed in both H1N1 and H5N1
Table 1 miRNAs differentially expressed in H1N1 and H5N1 infected NCI-H292 cells at different time points, respectively
A) MiRNAs differentially expressed in cells infected with H1N1 influenza A virus at 3, 6, 18, and 24 hours post-infection, respectively
3-hour Fold-change Regulation 6-hour Fold-change Regulation 18-hour Fold-change Regulation 24-hour Fold-change Regulation
hsa-miR-141 1.51 up hsa-miR-663 1.59 up hsa-miR-188-5p 1.57 up hsa-miR-1260 1.58 up
hsa-miR-23a 2 down hsa-miR-15a* 1.61 down hsa-miR-1260 1.77 down hsa-miR-1274a 1.66 up
hsa-miR-574-3p 2.83 down hsa-miR-1825 1.51 down hsa-miR-1274a 1.86 down hsa-miR-1274b 1.91 up
hsa-miR-574-5p 2.99 down hsa-miR-183* 1.71 down hsa-miR-1274b 1.69 down hsa-miR-141 1.51 up
hsa-miR-34b 1.52 down hsa-miR-141 1.66 down hsa-miR-183* 1.54 up
hsa-miR-494 1.56 down hsa-miR-17* 1.927 down hsa-miR-18b 1.64 up







B) MiRNAs differentially expressed in cells infected with H5N1 influenza A virus at 3, 6, 18, and 24 hours post-infection, respectively.
has-miR-141 1.9 up hsa-miR-483-3p 3.06 up hsa-miR-188-5p 2.01 up hsa-miR-1181 2.6 up
hsa-miR-181c* 1.8 up hsa-miR-let-7b* 2.02 up hsa-miR-923 3.39 up hsa-miR-1207-5p 2.7 up
hsa-miR-210 1.5 up hsa-miR-126 2.2 down hsa-miR-1260 3.11 down hsa-miR-1224-5p 2.02 up
hsa-miR-29b 1.62 up hsa-miR-20a* 2.42 down hsa-miR-1274a 3.57 down hsa-miR-1225-5p 2.44 up
hsa-miR-324-5p 1.759 up hsa-miR-362-5p 2.6 down hsa-miR-1274b 4.61 down hsa-miR-1246 4.39 up
hsa-miR-663 2.01 up hsa-miR-378 2.16 down hsa-miR-141 3.2 down hsa-miR-134 2.78 up
hsa-miR-197 1.64 down hsa-miR-454 2.32 down hsa-miR-18a 2.15 down hsa-miR-188-5p 2.49 up
hsa-miR-339-3p 1.925 down hsa-miR-574-5p 2.02 down hsa-miR-18b 3.34 down hsa-miR-1915 2.84 up
hsa-miR-574-3p 1.77 down hsa-miR-19a 2.32 down hsa-miR-572 2.92 up
hsa-miR-574-5p 2.41 down hsa-miR-21* 3.23 down hsa-miR-574-3p 3.75 up
hsa-miR-301a 2.32 down hsa-miR-574-5p 2.083 up
hsa-miR-30e 2.24 down hsa-miR-629* 2.85 up
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occurred in H1N1 infection were much lower than that
in H5N1 infection.
Confirmation of miRNA expression profile by real-time
PCR
The microarray data were further confirmed using
TaqMan quantitative RT-PCR (qRT-PCR) assays. There
were general consistency between TaqMan qRT-PCR as-
says and microarray results. It was found that six
miRNAs (miR-21*, miR-100*, miR-141, miR-1274a, miR-
1274b and miR-574-3p) were initially up-regulated at 3
hours post-infection. The degree of up-regulation was
more prominent in H5N1 infection (5 to 14 folds)


















































































Figure 1 Patterns of changes in cellular miRNA expression after influe
virus subtypes: H1N1/2002 or H5N1/2004 viruses at m.o.i. = 1, respectively.
were calculated by ΔΔCT method as compared with non-infection cell con
the graph represents the mean of fold-changes. The mean fold-changes of
non-infected controls ± SD (p* < 0.05).(p*<0.05). It was also found that these miRNAs became
down-regulated during 6-to-24 hours post-infection.
The degree of down-regulation was also higher in H5N1
infection than in H1N1 infection (Figure 1).
Target prediction of the miRNA expression profile
We then examined the list of targets predicted by
TargetScan computer software (http://www.targetscan.
org/) for the miRNA species that had the most consist-
ent and significant changes in expression following influ-
enza A virus infection (Table 2) [20]. The TargetScan
results showed that many of the target genes were in-
volved in the inflammatory response and cell death path-
ways. Interestingly, one of the target prediction results















































































nza A virus infection. NCI-H292 cells were infected with influenza A
qRT-PCR were used to quantitify the miRNA levels and fold-changes
trol (CC) and using 18S rRNA level for normalization. Each point on
miRNA in H1N1 or H5N1 infected cells were compared to that of
Table 2 The potential targets of selected miRNA: miR-21*,
miR-100*, miR-141, miR-1274a, miR-1274b, and miR-574
-3p are listed
miRNA Gene name Predicted target site
miR-21* CCL17 Small inducible cytokine A17 precursor
IL22 Interleukin-22 precursor
C2orf28 Apoptosis-related protein 3 precursor
TNFSF13 Tumor necrosis factor ligand
superfamily member 12
CCL1 Small inducible cytokine A1
precursor
CCL19 Small inducible cytokine A19 precursor
miR-100* IL13RA1 Interleukin-13 receptor alpha-1 chain
precursor (IL-13R-alpha-1)
CYTL1 Cytokine-like protein 1 precursor
IL18RAP Interleukin-18 receptor accessory
protein precursor
miR-141 CXCL12 chemokine (C-X-C motif) ligand 12
(stromal cell-derived factor 1)
TGFB2 transforming growth factor, beta 2
CRLF3 cytokine receptor-like factor 3
IFNAR1 interferon (alpha, beta and omega)
receptor 1
miR-574-3p NDUFA4L2 NADH dehydrogenase (ubiquinone)
1 alpha subcomplex, 4-like 2
miR-1274a TNFAIP3 tumor necrosis factor, alpha-induced
protein 3
TNFAIP8L2 tumor necrosis factor, alpha-induced
protein 8-like 2
BCL2L2 BCL2-like 2
BCLAF1 BCL2-associated transcription factor 1
BCLAF1 BCL2-associated transcription factor 1
miR-1274b TNFAIP8L2 tumor necrosis factor, alpha-induced
protein 8-like 2
IL1RAPL1 interleukin 1 receptor accessory
protein-like 1








Negative transfected control pre-miR-141










Figure 2 The TGF-β2 3′UTR is regulated by miR-141. NCI-H292
cells were transfected with pre-miR-141 and negative control,
respectively. The fold-changes of mRNA level of TGF-β2 as measured
by qRT-PCR at 24 hours after transfection. Fold-changes were
calculated by ΔΔCT method as compared with negatively
transfected cell control and using β-actin level for normalization.
Each point on the graph represents the mean fold-changes. The
mean fold-changes of TGF-β2 mRNA level was compared to that of
negative control ± SD (p* < 0.05).
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quence is: 3′- GGUAGAAAUGGUCUGUCACAAU - 5′,
while that of TGF-β2 3′UTR is: 5′-AGAGCCUUGGUUC
AUCAGUGUUA-3′. We had previously reported that
TGF-β2 was an important cytokine involved in the inflam-
matory response of avian influenza A virus infection [21]
and, together with the results showing that the expression
of miR-141 was altered during the time course of influ-
enza A virus infection, we selected miR-141 for further
functional analysis in this study.
MiR-141 represses the expression of TGF-β2 mRNA
In addition to the miRNA target prediction results, by
using ecoptic expression of miR-141, the level of TGF-
β2 mRNA was found to be significantly decreased inmiR-141 transfected cells but not in negative-control
miRNA mimic transfected cells (Figure 2). In this over-
expression system we could determine that the 3′UTR
was the miR-141 target and the decreased TGF-β2
mRNA level might be due to the binding of miR-141 to
the 3′UTR of TGF-β2 mRNA which reduced the half-
lives of TGF-β2 mRNA.Effect of inhibition of miR-141 in influenza A virus
infection
The functional relevance of changes in miR-141 expres-
sion during influenza A virus infection was assessed
using miRNA inhibitors. Chemically modified, single
stranded nucleic acids anti-miR miR-141 inhibitor and
negative control were transfected into H292 cells for 24
hours. We had previously shown that this was sufficient
time to obtain oligonucleotide delivery in H292 cells
when examining the inhibition of TGF-β2 mRNA ex-
pression. After the cells were pre-treated with anti-miR
miR-141 for 24 hours, they were then infected with
H1N1 or H5N1, respectively. After the infection pro-
cesses, anti-miR miR-141 was transfected again into the
virus infected cells and incubated for another 24 hours.
The results of this experiment showed that the anti-miR
miR-141 inhibitor could cause an increase in TGF-β2
protein expression in H1N1 or H5N1 infected cells, as
compared to cells only infected with H1N1 or H5N1 but
without anti-miR miR-141 inhibitor treatment (Figure 3).
The effect was also more prominent in H5N1 infection
































Figure 3 Measurement of TGF-β2 mRNA and protein level. NCI-H292 cells with or without treatment of miR-141 inhibitor, were infected with
influenza A virus subtypes: H1N1/2002 or H5N1/2004 viruses at m.o.i. = 1, respectively for 24 hours. qRT-PCR were used to quantitify the TGF-β2
mRNA levels and fold-changes were calculated by ΔΔCT method as compared with non-infection cell control (mock) and using endogeneous
actin mRNA level for normalization. TGF-β2 protein level was measured by enzyme-linked immunosorbent assay as compared with mock. Each
point on the graph respresents the mean fold-changes. The experimental mean fold-changes of mRNA and protein levels were compared to that
of mock controls ± SD (p* < 0.05), (p#< 0.05), respectively.
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In this study we examined the connection between influ-
enza A virus infection and the global patterns of cellular
miRNA expression. The major observations from this
work were that influenza A virus infection resulted in
the altered regulation of cellular miRNAs. Avian influ-
enza A virus can alter cellular miRNAs to a greater ex-
tent than that of seasonal human influenza A virus.
Influenza A virus affects the regulation of many cellu-
lar processes. In some cases, these changes are directed
by the virus for its advantage and others are cellular
defense responses to infection. Here, we found that in-
fluenza A virus infection led to altered regulation of cel-
lular miRNAs. Given the number of genes that can be
regulated by individual miRNAs and the number of
miRNAs expressed in cells, this greatly expands the
range of possible virus-host regulatory interactions. The
complexity is underscored by there being no uniform
global pattern of regulation; rather, it appears that indi-
vidual (or groups of ) miRNA are independently regu-
lated, some positively and some negatively. Persistent
and transient effects were seen, and changes in miRNA
expression profiles were linked to the time course of infec-
tion. As a summary, miR-1246, miR-663 and miR-574-3p
were up-regulated (>3-fold, p<0.05) at 24-hour post-
infection with subtype H5 as compared with non-infectedcontrol cells. Moreover, miR-100*, miR-21*, miR-141,
miR-1274a and miR1274b were found to be down-
regulated (>3-fold, p<0.05) in infection with subtype H5,
particularly at 18 or 24 hours post-infection as compared
with non-infected control cells. Interestingly, many of the
virally regulated miRNAs were predicted by TargetScan to
target important biological pathways, immune-related sig-
nal pathways and have altered regulation in some cellular
defense and some states of cellular differentiation [22].
In our study, we found that the expression of miR-141
was affected by influenza A virus infection. To validate the
in silico findings empirically on the target of miR-141, we
checked whether transient-transfection of anti- and pre-
mir-141 into NCI-H292 cells resulted in TGF-β2 regula-
tion. In our experiment, the transfection efficiency was an
important factor affecting the degree of regulation on the
target gene(s). In the case of higher transfection efficiency,
as more miRNA would be transfected into the cells, the
effect of gene(s) regulation by miRNA transfected would
be greater. In our study, the transfection efficiency was
about 78.2 ± 6.3% (mean ± SD), which was considered to
be adequate for further functional analyses. During trans-
fection, some oligonucleotide molecules were sequestered
in internal vesicles and physically separated from their tar-
gets in the cytoplasm; and then released during cell lysis.
Therefore monitoring miRNAs by qPCR after transfection
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cedure had highly recommended investigating the target
mRNAs and proteins instead of miRNA quantification.
The time point of 24-hour post-transfection or post-
infection was chosen for evaluation because miR-141 in-
duction was observed at the early stage of virus infection,
and sufficient time might be required for the miR-141 to
have effect on its target(s), so we had chosen 24-hour
post-transfection or post-infection for evaluation of the ef-
fect of this miRNA.
Indeed, upon detecting the TGF-β2 expression at
mRNA and protein levels, we found that the altered
miR-141 expression would affect the expression of the
cytokine- TGF-β2. Literature search on the background
of miR-141 confirmed that miR-141 is a member of the
miR-200 family (miR-200a, miR-200b, miR-200c, miR-
141 and miR-429). Previous studies of miR-141 were
mainly on its role in cancer. It has been reported that
miR-141 were markedly downregulated in cells that had
undergone epithelial to mesenchymal in response to
TGF-β. MiR-141 was also found to be overexpressed in
ovarian and colorectal cancers [23,24] and down-
regulated in prostate, hepatocellular, renal cell carcinoma
and in gastric cancer tissues [25-28] raising a controver-
sial issue about the role of miR-141 in cancer progres-
sion. Furthermore, the miR-200 family members play
roles in maintaining the epithelial phenotype of cancer
cells [29]. A member of this family - miR-200a was also
found to be differentially expressed in response to influ-
enza virus infection in another study [17]. The targets of
miR-200a are associated with viral gene replication and
the JAK-STAT signaling pathway, which is closely related
to type I interferon-mediated innate immune response
[17]. However, the effect of miR-141 on virus infection
was not known, except one recent report showing that
enterovirus can induce miR-141 and contribute to the
shutoff of host protein translation by targeting the trans-
lation initiation factor eIF4E [30].
In addition, evidence suggests that influenza A virus in-
fection reduces or promotes the expression of the host
miR-141 in a time dependent manner. We found that
TGF-β2 mRNA was suppressed in miR-141 overexpressed
cells. Our observation is in line with another study show-
ing that the 3′UTR of TGF-β2 mRNA contained a target
site for miR-141/200a and the expression of TGF-β2 was
significantly decreased in miR-141/200a transfected cells
[22]. Furthermore, miR-141 may not only work as transla-
tional repressors of target mRNAs, because it was ob-
served that they also caused a decrease in TGF-β2 mRNA
levels. These findings are similar to recent data demon-
strating that some miRNAs can alter the mRNA levels of
target genes [31]. This ability is probably independent of
the ability of these miRNAs to regulate the translation of
target mRNAs [14].We also noted that antagomiR-141 moderately in-
creased the accumulation of TGF-β2 protein during influ-
enza virus infection. This might be because, by the use of
anti-miR miR-141 inhibitor, which decreases the cellular
pool of miR-141, the translation control of the TGF-β2
mRNA was subsequently released and caused the TGF-β2
protein to express and accumulate during virus infection.
However, it was also observed that when there was an in-
crease in TGF-β2 mRNA level, the corresponding TGF-β2
protein expression level would be increased, except in the
case of non-miR-141-inhibitor treated H5N1 infected
cells. In this case, there was a decrease in TGF-β2 mRNA
level, while the TGF-β2 protein was increased. This might
be explained by the fact that TGF-β2 mRNA degradation
induced by miR-141 might be much faster than that of the
corresponding protein degradation.
Recently, we had also reported that H1N1 was the only
subtype that could induce a sustained increase in TGF-β2
at protein level [21]. That observation coincides with our
results in this study, showing that H1N1 infection induced
a little amount of miR-141 expression, while H5N1 infec-
tion induced a higher amount of miR-141 expression at
the early phase of infection. As a consequence of the
higher amount of miR-141 in H5N1 infection, TGF-β2 ex-
pression might be more greatly reduced than that in
H1N1 infection. Since TGF-β2 can act as both an im-
munosuppressive agent and a potent proinflammatory
molecule through its ability to attract and regulate inflam-
matory molecules, it plays a vital role in T-cell inhibition.
Furthermore, it has been reported that TGF-β2 inhibits
Th1 cytokine-mediated induction of CCL-2/MCP-1,
CCL-3/MIP-1α, CCL-4/MIP-1β, CCL-5/RANTES, CCL-9
/MIP-1γ, CXCL-2/MIP-2, and CXCL-10/IP-10 [32]. More-
over, the pro-inflammatory responses during influenza
A virus infection are tightly controlled by anti-inflammatory
mediators, such as TGF-β2, to protect the easily
damageable lung tissue from destructive side effects asso-
ciated with virus induced inflammation. Therefore, the
downregulation of TGF-β2 protein by miR-141 may be an
important step in the excessive inflammation progression
during influenza A virus infection, particularly in H5N1
infection. However, whether the recovery of TGF-β2 ex-
pression by anti-miR miR-141 inhibitor could resolve the
hypercytokinemia stage of H5N1 infection needs to be
further studied.
Although our findings were obtained from an in vitro
model, we could apply these to the real situation of an
in vivo model or tissue comprised of different cell types.
In real bronchial environments, lung epithelial cells are
the key target of influenza viruses [33,34]. After these
cells are infected, they will activate an inflammatory cas-
cade which launches a quick antimicrobial reaction and
directs adaptive immunity to mount a protective re-
sponse. Bronchial epithelial cells therefore modulate the
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and T lymphocytes through cytokines and chemokines. Cy-
tokines and chemokines generally function in an autocrine
(on the producing cell itself) or paracrine (on nearby cells)
manner. These mediators will contribute to the generation
of a specific bronchial homeostatic microenvironment that
affects the way in which the body copes with the viruses.
This homeostatic “circuit” can inhibit excessive inflamma-
tory response in lung tissues [35]. For example, TGF-β had
been reported to mediate a cross-talk between alveolar
macrophages and epithelial cells [36]. However, our find-
ings show that, during highly pathogenic H5N1 avian virus
infection, miR-141 would be induced shortly after infection.
With high level of miR-141, the expression of TGF-β would
be suppressed from the lung epithelial cells. Without suffi-
cient TGF- β, the pro-inflammatory response might not be
tightly controlled in cases of highly pathogenic H5N1
avian virus infection. This might explain the mechan-
ism concerning bronchial infiltration of inflammatory
cells, particularly lymphocytes and eosinophils, and the
subsequent hyperresponsiveness of the bronchial wall
induced by viral infection.
Our study has some limitations that will need to be
addressed in future studies. Firstly, we did not assess the
roles of other miRNAs whose expression were also al-
tered after infection. The miRNA microarrays that we
used did not contain probes for every known miRNA;
thus it is possible that influenza A virus infection affects
the expression of some other miRNAs not yet covered
by the kit used in the current study. Secondly, the virus
may interact with miRNA regulatory pathways differ-
ently in other cell or tissue types, or in other physio-
logical status.
Conclusions
In conclusion, based on the broad-catching miRNA
microarray approach, we found that dysregulation of
miRNA expression is mainly observed in highly patho-
genic avian influenza infection. We identified that miR-
141 was induced at early time points upon influenza A
virus infection. The induction was higher in H5N1 infec-
tion than that of seasonal H1N1 infection. Moreover,
TGF-β2, which plays an important role in regulating in-
flammatory processes, was identified as a target of miR-
141 binding. As a result, influenza A virus infection, in
particular highly pathogenic H5N1, could affect the in-
flammatory processes via miR-141 induction.
Methods
Virus isolates
The influenza A H5N1 virus (A/Thai/KAN1/2004) (H5N1/
2004) was isolated from a patient with fatal infection in
Thailand in 2004. To serve as a comparison, a human sea-
sonal H1N1 strain isolated in 2002 – (A/HongKong/CUHK-13003/2002) (H1N1/2002) was included. The re-
search use of these samples was approved by the Joint
CUHK - NTEC Research Ethics Committee, Hong Kong
and the strains were isolated from the patients as part of
standard care.
Cell cultures
The bronchial epithelial cells - NCI-H292, derived from
human lung mucoepidermoid carcinoma cells (ATCC,
CRL-1848, Rockville, MD, USA), were grown as mono-
layers in RPMI-1640 medium (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal bovine serum (FBS), 100
U/ml penicillin and 100 μg/mL streptomycin (all from
Gibco, Life Technology, Rockville, Md., USA) at 37°C in
a 5% CO2 incubator. NCI-H292 cells were used as an in-
vitro model to study host cellular responses to viral
infection.
Mandin-Darby canine kidney (MDCK) cells were used
for growing stocks of influenza virus isolates. MDCK
cells were grown and maintained in Eagles Minimal Es-
sential Media (MEM) containing 2% FBS, 100 U/ml
penicillin and 100 μg/mL streptomycin (all from Gibco,
Life Technology).
Infection of cell culture with influenza A viruses
NCI-H292 cells were grown to confluence in sterile T75
tissue culture flasks for the inoculation of virus isolate at
a multiplicity of infection (m.o.i.) of one. After 1 hour of
absorption, the virus was removed and 2 ml of fresh
RPMI-1640 media with 2% FBS, 100 U/ml penicillin,
100 μg/mL streptomycin and 1μg/ml L-1-tosylamido-
2-phenylethyl chloromethyl ketone (TPCK)-treated
trypsin (all from Gibco, Life Technology) was added,
and incubated at 37°C in 5% CO2 humidified air.
RNA extraction
Total RNA was extracted from normal and infected
NCI-H292 cells using Trizol reagent (Invitrogen) follow-
ing the manufacturer’s protocol. RNA pellets were
resuspended in RNase-free water. The RNA integrity
was assessed using Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA, USA).
MiRNA expression profiling
MiRNAs were labeled using the Agilent miRNA labeling
reagent and hybridized to Agilent human miRNA arrays
according to the manufacturer’s protocol. Briefly, total
RNA (100 ng) was dephosphorylated and ligated with 3′,
5′-cytidine bisphosphate (pCp-Cy3). Labeled RNA was
purified and hybridized to Agilent miRNA arrays with
eight identical arrays per slide, with each array containing
probes interrogating 866 human miRNAs. Images were
scanned with the Agilent microarray scanner (Agilent
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extraction software (Agilent Technologies).
Statistical analysis of microarray data
The cells were infected with either (A) the H1N1/2002
strain or (B) the H5N1/2004 strain, or (C) mock-
infected with PBS (no infection control). Cell samples
were collected at 3, 6, 18 and 24 hours post-infection.
Each miRNA array allowed us to interrogate 866 human
miRNAs. The results were analyzed using Genespring
GX 10.0.2 software (Agilent Technologies). Firstly, the
16 arrays were quantile normalized together. Then, stu-
dent’s paired t-test was applied to test if there was a sig-
nificant difference between (A) the H1N1/2002-infected
and (C) mock-infected, no infection control (matched
for the time post-infection), (B) the H5N1/2004-infected
and (C) mock-infected control, respectively. The resultant
P-values were adjusted for multiple testing by using the
Benjamini-Hochberg correction of the false-discovery rate
[37]. MiRNAs with this adjusted P-value <= 0.05 were
considered as differentially expressed. Those miRNAs,
that are more than or equal to 3.5-fold up or down regu-
lated were subjected to a second analysis using real-time
RT-PCR.
MicroRNA profiling data resource
The data discussed in this publication have been deposited
in NCBI’s Gene Expression Omnibus [38] and are access-
ible through GEO Series accession number GSE44455.
TaqMan Real Time RT-PCR (qRT-PCR) for quantification of
miRNAs
Total RNA was reverse transcribed with looped miRNA-
specific RT primers contained in the TaqMan MicroRNA
assays ((Applied Biosystems, Foster City, CA). Briefly,
single-stranded cDNA was synthesized from 10 ng total
RNA in 15-μL reaction volume with TaqMan MicroRNA
reverse transcription kit (Applied Biosystems), according
to the manufacturer’s protocol. The reaction was incu-
bated at 16°C for 30 min followed by 30 min at 42°C and
inactivation at 85°C for 5 min. Each cDNA was amplified
with sequence-specific TaqMan microRNA assays
(Applied Biosystems). PCR reactions were performed
on an Applied Biosystems Step One sequence detec-
tion system in 10 μl volumes at 95°C for 10 min,
followed by 40 cycles of 95°C for 15 sec and 60°C for
1 min. All samples were tested in triplicate. The
threshold cycle (Ct) values obtained with the SDS
software (Applied Biosystems) were compared with
the Ct obtained from 18S rRNA assay (Applied
Biosystems) for the normalization of total RNA input.
The fold-change was calculated based on Ct changes
of mean medium Ct minus individual Ct of a miRNA.
Each experiment was performed in triplicate.qRT-PCR for quantification of TGF-β2 mRNA level
Total RNA extracted from cell cultures was reversely
transcripted to cDNA using the poly(dT) primers and
Superscript III reverse transcriptase (Invitrogen), and
quantified by real-time PCR. The sense and antisense
primers used in real-time PCR for measuring TGF-β2
were: (Forward: 5′-CCAAAGGGTACAATGCCAAC-3′;
Reverse: 5′-TAAGCTCAGGACCCTGCTGT-3′). The real-
time PCR reactions were performed in triplicates using
the SYBER Green PCR Master Mix (Applied Biosystems).
The PCR conditions were 95 °C for 5 min, followed by 50
cycles of 95 °C for 30 sec, 55 °C for 30 sec, and 72 °C for
30 sec. The expression of β-actin gene was also quantified
in a similar way for normalization. Comparative delta-
delta CT method was used to analyze the results where ex-
pression level of the respective gene at the corresponding
time point in non-transfected cells was regarded as one
[39,40]. Each experiment was performed in triplicate.Enzyme-linked immunosorbent assay (ELISA)
measurement of TGF-β2 protein level
Cell culture supernatant was collected at 24 hours post-
infection for the analysis of TGF-β2 expression. The total
TGF-β2 protein level was measured by enzyme-linked im-
munosorbent assay (Emax® ImmunoAssay System, Promega,
Madison, WI, USA) according to the manufacturer’s proce-
dures. Each experiment was performed in triplicate.Reverse transfection of a mimic or an inhibitor of miR-141
The cells were transfected in suspension after trypsinisation
with 60 nM anti-miR, pre-miR or negative control (Applied
Biosystems). For the assay, 1x105 cells per mL were
transfected per well of a 24-well plate. Transfection com-
plexes were prepared in OptiMEM (Invitrogen) with
1.5 μL/24-well of siPORT NeoFx transfection agent
(Ambion, Austin, TX, USA). At 24 hours post-
transfection, the cells were lysed for qRT-PCR analysis
or subjected to H1N1 or H5N1 virus infection. The
transfection efficiency was calculated from the per-
centage of fluorescent cells that were observed using
florescence microscopy after the transfection of fluor-
escein isothiocyanate (FITC)-labeled short nucleotide
primers in separate controls. The transfection effi-
ciency was about 78.2 ± 6.3% (mean ± SD), which was
considered to be adequate for the functional analyses.
The human miR-1 miRNA was also used as a positive
control. In this control, the human miR-1 miRNA
mimic effectively down-regulated the expression of
twinfilin-1 (also known as PTK9) by 80% at the mRNA
level as detected by real-time PCR using TaqMan®
Gene Expression Assays (Applied Biosystems) for
PTK9. This positive control proved the effective deliv-
ery and activity of Pre-miR miRNA Precursor. We
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